Literature DB >> 16557588

Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): Shedding of soluble IL-6R and activation of STAT3 signaling.

Sankichi Horiuchi1, Norio Yamamoto, Md Zahidunnabi Dewan, Yoshiaki Takahashi, Atsuya Yamashita, Tsutomu Yoshida, Mari A Nowell, Peter J Richards, Simon A Jones, Naoki Yamamoto.   

Abstract

Human T-cell leukemia virus type-I (HTLV-I) encodes for the viral protein Tax, which is known to significantly disrupt transcriptional control of cytokines, cytokine receptors and other immuno-modulatory proteins in T cells. Specific dysregulation of these factors can alter the course and pathogenesis of infection. Soluble interleukin-6 receptor (sIL-6R) was shown to circulate at elevated levels in HTLV-I-infected patients, and high expressions of IL-6R and sIL-6R by HTLV-I-infected T cells were clinically and experimentally associated with Tax activity. To examine roles of Tax in expression of the IL-6R gene, the JPX-9 cell line was used, which is derived from Jurkat cell line expressing Tax cDNA. Over-expression of Tax enhanced IL-6R expression but not in Tax mutant JPX-9/M cell line. The clinical relevance of these observations was further demonstrated by ELISA using sera obtained from HTLV-I-infected patients. Our results revealed that sIL-6R levels were apparently elevated in HAM/TSP patients who were expressing Tax in their cells, while ATL patients' cells barely expressed Tax. HTLV-I-infected T-cell lines stimulated by IL-6/sIL-6R showed gp130-mediated STAT3 activity. IL-6/sIL-6R enhanced proliferation of HTLV-I-infected T cells in association with activation of STAT3. Consequently, Tax-mediated regulations of IL-6R and sIL-6R observed in HTLV-I-associated disorders may contribute to proliferation of HTLV-I-infected T cells through activation of inducible STAT3, and ultimately affect malignant growth and transformation of T cells by HTLV-I. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557588     DOI: 10.1002/ijc.21918

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  The autophagy molecule Beclin 1 maintains persistent activity of NF-κB and Stat3 in HTLV-1-transformed T lymphocytes.

Authors:  Li Chen; Dan Liu; Yang Zhang; Huan Zhang; Hua Cheng
Journal:  Biochem Biophys Res Commun       Date:  2015-08-25       Impact factor: 3.575

Review 2.  Human T-cell lymphotropic virus type 1 and its oncogenesis.

Authors:  Lan-Lan Zhang; Jing-Yun Wei; Long Wang; Shi-le Huang; Ji-Long Chen
Journal:  Acta Pharmacol Sin       Date:  2017-04-10       Impact factor: 6.150

3.  Effect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro.

Authors:  Emanuela Balestrieri; Claudia Matteucci; Arianna Ascolani; Anna Piperno; Roberto Romeo; Giovanni Romeo; Ugo Chiacchio; Antonio Mastino; Beatrice Macchi
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

4.  Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells.

Authors:  Eva M Briso; Oliver Dienz; Mercedes Rincon
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

5.  HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia.

Authors:  Morgan Thénoz; Céline Vernin; Hussein Mortada; Maroun Karam; Christiane Pinatel; Antoine Gessain; Thomas R Webb; Didier Auboeuf; Eric Wattel; Franck Mortreux
Journal:  Retrovirology       Date:  2014-12-18       Impact factor: 4.602

Review 6.  Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases.

Authors:  Nicolas Futsch; Gabriela Prates; Renaud Mahieux; Jorge Casseb; Hélène Dutartre
Journal:  Viruses       Date:  2018-12-05       Impact factor: 5.048

Review 7.  Lymphotropic Viruses: Chronic Inflammation and Induction of Cancers.

Authors:  Edward W Harhaj; Noula Shembade
Journal:  Biology (Basel)       Date:  2020-11-10

8.  Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy.

Authors:  Chihiro Iwao; Kunihiko Umekita; Shunichi Miyauchi; Masatoshi Kimura; Yuki Rikitake; Koushou Iwao; Mao Rikitake; Ayako Aizawa; Takeshi Kawaguchi; Yumi Kariya; Motohiro Matsuda; Ichiro Takajo; Kazutaka Shiomi; Akihiko Okayama
Journal:  Intern Med       Date:  2020-04-23       Impact factor: 1.271

9.  Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL.

Authors:  Carmina Louise Hugo Guerrero; Yoshiko Yamashita; Megumi Miyara; Naoki Imaizumi; Megumi Kato; Shugo Sakihama; Masaki Hayashi; Takashi Miyagi; Kaori Karimata; Junnosuke Uchihara; Kazuiku Ohshiro; Junpei Todoroki; Sawako Nakachi; Satoko Morishima; Kennosuke Karube; Yuetsu Tanaka; Hiroaki Masuzaki; Takuya Fukushima
Journal:  Blood Adv       Date:  2020-03-24

10.  HTLV-1 Tax deregulates autophagy by recruiting autophagic molecules into lipid raft microdomains.

Authors:  T Ren; Y Takahashi; X Liu; T P Loughran; S-C Sun; H-G Wang; H Cheng
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.